Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette M Molinaro

Showing results (201-210 of 208) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 208 results.
Journal of Neurosurgery. Spine|October 2, 2020
Consensus-based perioperative protocols during the COVID-19 pandemicPraveen V Mummaneni, John F Burke, Andrew K Chan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 4, 2023
Interactive Effects of Molecular, Therapeutic, and Patient Factors on Outcome of Diffuse Low-Grade GliomaShawn L Hervey-Jumper, Yalan Zhang, Joanna J Phillips, et al.
Neuro-Oncology|November 19, 2024
Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responsesCalixto-Hope G Lucas, Nadeem N Al-Adli, Jacob S Young, et al.
The New England Journal of Medicine|June 11, 2015
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in TumorsJeanette E Eckel-Passow, Daniel H Lachance, Annette M Molinaro, et al.
JAMA Oncology|February 7, 2020
Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed GlioblastomaAnnette M Molinaro, Shawn Hervey-Jumper, Ramin A Morshed, et al.
The Lancet. Oncology|November 27, 2025
A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect groupPhilipp Karschnia, Jacob S Young, Maarten M J Wijnenga, et al.
Cell|May 2, 2024
RNA aggregates harness the danger response for potent cancer immunotherapyHector R Mendez-Gomez, Anna DeVries, Paul Castillo, et al.
Nature|November 22, 2019
Longitudinal molecular trajectories of diffuse glioma in adultsFloris P Barthel, Kevin C Johnson, Frederick S Varn, et al.
Pageof 21

Showing results (201-210 of 208) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 208 results.
Journal of Neurosurgery. Spine|October 2, 2020
Consensus-based perioperative protocols during the COVID-19 pandemicPraveen V Mummaneni, John F Burke, Andrew K Chan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 4, 2023
Interactive Effects of Molecular, Therapeutic, and Patient Factors on Outcome of Diffuse Low-Grade GliomaShawn L Hervey-Jumper, Yalan Zhang, Joanna J Phillips, et al.
Neuro-Oncology|November 19, 2024
Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responsesCalixto-Hope G Lucas, Nadeem N Al-Adli, Jacob S Young, et al.
The New England Journal of Medicine|June 11, 2015
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in TumorsJeanette E Eckel-Passow, Daniel H Lachance, Annette M Molinaro, et al.
JAMA Oncology|February 7, 2020
Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed GlioblastomaAnnette M Molinaro, Shawn Hervey-Jumper, Ramin A Morshed, et al.
The Lancet. Oncology|November 27, 2025
A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect groupPhilipp Karschnia, Jacob S Young, Maarten M J Wijnenga, et al.
Cell|May 2, 2024
RNA aggregates harness the danger response for potent cancer immunotherapyHector R Mendez-Gomez, Anna DeVries, Paul Castillo, et al.
Nature|November 22, 2019
Longitudinal molecular trajectories of diffuse glioma in adultsFloris P Barthel, Kevin C Johnson, Frederick S Varn, et al.
Pageof 21